The Effect of Art Therapy on Disease Severity and Anxiety Levels in Inpatients at a Psychiatry Clinic

NCT ID: NCT07162428

Last Updated: 2025-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-15

Study Completion Date

2025-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine the effect of art therapy applied to inpatients in the psychiatry ward on disease severity and anxiety levels. Art therapy is considered a complementary intervention that can positively contribute to the psychiatric recovery process by facilitating the expression and regulation of an individual's emotional state.

This research will be conducted with a randomized controlled design and aims to demonstrate the effectiveness of art therapy practices within the clinical process through objective data. The originality of the study lies in the fact that art therapy will be implemented with individuals hospitalized in an acute psychiatric ward. In this respect, the study provides the opportunity to evaluate the applicability of art therapy even during crisis periods and carries the potential to make significant practice-oriented contributions to the field of mental health.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mental health is currently defined as a significant public health issue on a global scale. Mental disorders manifest across a wide spectrum, ranging from mild anxiety disorders to behavioral abnormalities. Psychiatric illnesses not only diminish individuals' quality of life but also impose substantial social and economic burdens on healthcare systems.

Alternative and complementary treatment methods are gaining increasing importance in alleviating this burden. In this context, art therapy has recently attracted attention as a supportive method in psychiatric treatments. The British Association of Art Therapists (BAAT) defines art therapy as "a form of psychotherapy in which art materials are used as the primary medium of expression and communication," whereas the American Art Therapy Association (AATA) defines it as "a mental health and human services profession that integrates creative processes, psychological theory, and human experience".

Art therapy represents a multidimensional approach that encompasses various practices such as drama therapy, dance-movement psychotherapy, body therapy, music therapy, painting, drawing, and crafts. This form of therapy aims to promote recovery not only at the mental level but also at the physical and emotional levels in the treatment of psychiatric disorders .

Research has shown that art therapy enhances individual expressive abilities, facilitates emotion regulation, and provides a personalized healing process. It has been demonstrated to yield effective results particularly in post-traumatic stress disorder (PTSD), personality disorders, and mood disorders. Furthermore, its effectiveness in reducing depression in elderly individuals has been supported by randomized controlled trials. Similarly, studies on reducing anxiety levels in children have also reported positive outcomes.

This study aims to investigate the effect of art therapy practices on disease severity and anxiety levels among inpatients in a psychiatric ward, using a randomized controlled trial design. The originality of this study lies in its implementation of art therapy with individuals hospitalized in an acute psychiatric ward. In this regard, examining the direct impact of art therapy within the clinical process has the potential to provide significant practical contributions for both practitioners and the healthcare system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychiatric Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomly assigned to either the art therapy intervention group or the control group receiving standard care
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

This is an open-label study; neither participants nor investigators are blinded to the intervention.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Art Therapy Intervention

Participants in this group will receive art therapy sessions in addition to standard psychiatric care. The intervention will consist of 3 sessions per week, conducted on 5 consecutive days, with each session lasting approximately 50 minutes. Sessions will be carried out in groups of 8 participants and will focus on creative expression through drawing and painting. All sessions will be facilitated by a trained art therapist.

Group Type EXPERIMENTAL

Art Therapy

Intervention Type BEHAVIORAL

The art therapy sessions will be conducted by a certified art therapist who has completed a two-year training program, together with a psychiatric nurse who has completed a 4-hour training course on "Severe Personality Disorders and Therapeutic Interventions - Art Therapy." A clinical nurse and a psychiatry resident will also participate as observers. The therapist will deliver the intervention through semi-structured sessions, following a predefined content and method. These sessions are referred to as Semi-Structured Art Therapy Sessions.

Control Group (Standard Care)

Participants in this group will receive standard psychiatric care without additional art therapy sessions.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Art Therapy

The art therapy sessions will be conducted by a certified art therapist who has completed a two-year training program, together with a psychiatric nurse who has completed a 4-hour training course on "Severe Personality Disorders and Therapeutic Interventions - Art Therapy." A clinical nurse and a psychiatry resident will also participate as observers. The therapist will deliver the intervention through semi-structured sessions, following a predefined content and method. These sessions are referred to as Semi-Structured Art Therapy Sessions.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Age 18 years or older.

Currently hospitalized in the psychiatry clinic and expected to remain hospitalized during the study period.

No medical condition such as intellectual disability or organic mental disorder that would interfere with the administration of scales and tests.

A PANSS score of ≤62 (since a score of 61 is considered the remission criterion in schizophrenia, patients scoring 62 or below will be included).

A score between 5-18 on the Young Mania Rating Scale.

Receiving treatment in the clinic for at least 3 days.

Providing verbal and/or written informed consent to participate in the study.

Exclusion Criteria

Being in an acute psychotic episode or having severe psychotic symptoms (e.g., severe delusions, hallucinations) making the patient unsuitable for group participation.

Clinical conditions involving excessive agitation or homicidal risk that make group participation inappropriate.

Inability to actively participate in art therapy due to visual, hearing, or severe motor impairments.

Patients for whom discharge is planned during the clinical course (e.g., those scheduled for discharge in less than 3 days).

Diagnosis of an organic mental disorder (e.g., dementia, delirium).

Severe physical illness or motor impairment preventing participation in group activities
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Koç University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tuğba ŞAHİN TOKATLIOĞLU, Dr.

Role: CONTACT

+90539 474 87 07

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

tugbasahin

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Digital Silence and Mental Health
NCT07147829 NOT_YET_RECRUITING NA